SAKAR HEALTHCARE LIMITED

SAKAR

Small Cap | Pharmaceuticals
440
+5.25 (+1.2%)

Stock price as on 06 Feb 2026 at 15:29 PM

Sakar healthcare limited share price update

As of the latest trading session, Sakar Healthcare Limited share price is currently at ₹440, which is up by ₹5.25 from its previous closing. Today the...

Sakar Healthcare Limited stock performance

Today’s low

₹420.55

Today’s high

₹445

₹440

52 week low

₹210.1

52 week high

₹465

₹440
Open
₹436.15
Previous close
₹434.75
Share volume
91,683
Total traded value (Lakh)
₹400.92
Upper circuit
₹521.70
Lower circuit
₹347.80

Sakar Healthcare Limited fundamentals

Market cap (Cr)
₹973.00
P/E ratio (TTM)
38.34
Book value per share
₹136.33
Beta
0.73
Return on equity
6.39%
Earnings per share (TTM)
₹11.34
Dividend yield
0%
Net profit/quarter (Cr)
₹10.25

Sakar Healthcare Limited financials

(Values in Cr)
Revenue
Net income

Particulars

Dec 25 (₹ value in crores)

Revenue

₹70.34

Operating expense

₹59.90

Net income

₹10.25

Net profit margin

14.57%

Earning per share

₹4.59

EBITDA

₹19.09

Effective tax rate

6.39%

Particulars

Sep 25 (₹ value in crores)

Revenue

₹57.56

Operating expense

₹53.42

Net income

₹4.54

Net profit margin

7.88%

Earning per share

₹2.03

EBITDA

₹12.57

Effective tax rate

15.29%

Particulars

Jun 25 (₹ value in crores)

Revenue

₹52.74

Operating expense

₹47.74

Net income

₹4.67

Net profit margin

8.85%

Earning per share

₹2.11

EBITDA

₹13.09

Effective tax rate

13.19%

Particulars

Mar 25 (₹ value in crores)

Revenue

₹50.24

Operating expense

₹44.18

Net income

₹5.76

Net profit margin

11.46%

Earning per share

₹2.66

EBITDA

₹15.91

Effective tax rate

7.69%

Particulars

Dec 24 (₹ value in crores)

Revenue

₹43.42

Operating expense

₹38.19

Net income

₹4.53

Net profit margin

10.43%

Earning per share

₹2.08

EBITDA

₹12.01

Effective tax rate

17.15%

(Values in Cr)
Revenue
Net income

Particulars

Mar 25 (₹ value in crores)

Revenue

₹177.58

Operating expense

₹157.32

Net income

₹17.50

Net profit margin

9.85%

Earning per share

₹7.97

EBITDA

₹50.95

Effective tax rate

18.71%

Particulars

Mar 24 (₹ value in crores)

Revenue

₹153.35

Operating expense

₹140.63

Net income

₹11.67

Net profit margin

7.61%

Earning per share

₹5.64

EBITDA

₹41.54

Effective tax rate

26.6%

Particulars

Mar 23 (₹ value in crores)

Revenue

₹133.36

Operating expense

₹121.15

Net income

₹12.76

Net profit margin

9.56%

Earning per share

₹6.58

EBITDA

₹37.82

Effective tax rate

24.4%

Particulars

Mar 22 (₹ value in crores)

Revenue

₹128.23

Operating expense

₹111.39

Net income

₹15.24

Net profit margin

11.88%

Earning per share

₹8.77

EBITDA

₹31.58

Effective tax rate

19.83%

Particulars

Mar 21 (₹ value in crores)

Revenue

₹94.74

Operating expense

₹82.67

Net income

₹10.69

Net profit margin

11.28%

Earning per share

₹6.88

EBITDA

₹23.78

Effective tax rate

19.25%

(Values in Cr)
Revenue
Net income

Particulars (annual)

Mar 25 (₹ value in crores)

Book value per share

₹128.75

Return on Equity (ROE)

6.39%

Return on Capital Employed (ROCE)

8.37%

Total debt to equity ratio

0.3

EBITDA margin

28.69%

Particulars (annual)

Mar 24 (₹ value in crores)

Book value per share

₹118.41

Return on Equity (ROE)

5.36%

Return on Capital Employed (ROCE)

7.36%

Total debt to equity ratio

0.46

EBITDA margin

27.09%

Particulars (annual)

Mar 23 (₹ value in crores)

Book value per share

₹91.04

Return on Equity (ROE)

8.48%

Return on Capital Employed (ROCE)

8.85%

Total debt to equity ratio

0.7

EBITDA margin

28.35%

Particulars (annual)

Mar 22 (₹ value in crores)

Book value per share

₹74.45

Return on Equity (ROE)

13.49%

Return on Capital Employed (ROCE)

12.05%

Total debt to equity ratio

0.6

EBITDA margin

24.63%

Particulars (annual)

Mar 21 (₹ value in crores)

Book value per share

₹63.04

Return on Equity (ROE)

11.88%

Return on Capital Employed (ROCE)

13.07%

Total debt to equity ratio

0.33

EBITDA margin

25.09%

(Values in Cr)
Revenue
Net income

Particulars (annual)

Mar 25 (₹ value in crores)

Book value per share

₹128.78

Return on Equity (ROE)

6.39%

Return on Capital Employed (ROCE)

8.37%

Total debt to equity ratio

0.3

EBITDA margin

28.69%

Particulars (annual)

Mar 24 (₹ value in crores)

Book value per share

₹118.44

Return on Equity (ROE)

5.36%

Return on Capital Employed (ROCE)

7.36%

Total debt to equity ratio

0.46

EBITDA margin

27.09%

Particulars (annual)

Mar 23 (₹ value in crores)

Book value per share

₹91.09

Return on Equity (ROE)

8.48%

Return on Capital Employed (ROCE)

8.85%

Total debt to equity ratio

0.7

EBITDA margin

28.35%

Particulars (annual)

Mar 22 (₹ value in crores)

Book value per share

₹74.50

Return on Equity (ROE)

13.49%

Return on Capital Employed (ROCE)

12.05%

Total debt to equity ratio

0.6

EBITDA margin

24.63%

Particulars (annual)

Mar 21 (₹ value in crores)

Book value per share

₹63.04

Return on Equity (ROE)

11.89%

Return on Capital Employed (ROCE)

13.07%

Total debt to equity ratio

0.33

EBITDA margin

25.1%

(Values in Cr)
Revenue
Net income

Particulars

Mar 25 (₹ value in crores)

Cash and short term investments

₹0.30

Total assets

₹415.26

Total liabilities

₹415.26

Total equity

₹285.47

Shares outstanding

₹2.19

Price to book ratio

₹1.64

Return on assets (%)

4.21%

Return on capital

4.86%

Particulars

Mar 24 (₹ value in crores)

Cash and short term investments

₹0.46

Total assets

₹388.65

Total liabilities

₹388.65

Total equity

₹262.33

Shares outstanding

₹2.17

Price to book ratio

₹3.11

Return on assets (%)

3%

Return on capital

3.52%

Particulars

Mar 23 (₹ value in crores)

Cash and short term investments

₹0.09

Total assets

₹336.33

Total liabilities

₹336.33

Total equity

₹173.34

Shares outstanding

₹1.90

Price to book ratio

₹2.20

Return on assets (%)

3.79%

Return on capital

4.48%

Particulars

Mar 22 (₹ value in crores)

Cash and short term investments

₹0.02

Total assets

₹267.76

Total liabilities

₹267.76

Total equity

₹127.46

Shares outstanding

₹1.71

Price to book ratio

₹1.81

Return on assets (%)

5.66%

Return on capital

7%

Particulars

Mar 21 (₹ value in crores)

Cash and short term investments

₹0.08

Total assets

₹177.79

Total liabilities

₹177.79

Total equity

₹98.45

Shares outstanding

₹1.56

Price to book ratio

₹1.79

Return on assets (%)

6%

Return on capital

7.71%

(Values in Cr)
Revenue
Net income

Particulars

Mar 25 (₹ value in crores)

Cash and short term investments

₹0.30

Total assets

₹415.34

Total liabilities

₹415.34

Total equity

₹285.56

Shares outstanding

₹2.19

Price to book ratio

₹1.64

Return on assets (%)

4.21%

Return on capital

4.85%

Particulars

Mar 24 (₹ value in crores)

Cash and short term investments

₹0.46

Total assets

₹388.74

Total liabilities

₹388.74

Total equity

₹262.41

Shares outstanding

₹2.17

Price to book ratio

₹3.11

Return on assets (%)

3%

Return on capital

3.52%

Particulars

Mar 23 (₹ value in crores)

Cash and short term investments

₹0.09

Total assets

₹336.42

Total liabilities

₹336.42

Total equity

₹173.43

Shares outstanding

₹1.90

Price to book ratio

₹2.20

Return on assets (%)

3.79%

Return on capital

4.48%

Particulars

Mar 22 (₹ value in crores)

Cash and short term investments

₹0.02

Total assets

₹267.84

Total liabilities

₹267.84

Total equity

₹127.53

Shares outstanding

₹1.71

Price to book ratio

₹1.81

Return on assets (%)

5.69%

Return on capital

7.02%

Particulars

Mar 21 (₹ value in crores)

Cash and short term investments

₹0.08

Total assets

₹177.80

Total liabilities

₹177.80

Total equity

₹98.46

Shares outstanding

₹1.56

Price to book ratio

₹1.79

Return on assets (%)

6.01%

Return on capital

7.71%

(Values in Cr)
Revenue
Net income

Particulars

Mar 25 (₹ value in crores)

Net income

₹21.52

Cash from operations

₹36.40

Cash from investing

-₹30.70

Cash from financing

-₹3.47

Net change in cash

-₹0.15

Free cash flow

₹68.68

Particulars

Mar 24 (₹ value in crores)

Net income

₹15.89

Cash from operations

₹27.61

Cash from investing

-₹51.53

Cash from financing

₹27.44

Net change in cash

₹0.37

Free cash flow

₹87.17

Particulars

Mar 23 (₹ value in crores)

Net income

₹16.87

Cash from operations

₹37.60

Cash from investing

-₹74.37

Cash from financing

₹41.09

Net change in cash

₹0.06

Free cash flow

₹119.80

Particulars

Mar 22 (₹ value in crores)

Net income

₹19.00

Cash from operations

₹35.52

Cash from investing

-₹90.37

Cash from financing

₹54.62

Net change in cash

-₹0.05

Free cash flow

₹133.05

Particulars

Mar 21 (₹ value in crores)

Net income

₹13.23

Cash from operations

₹15.30

Cash from investing

-₹46.83

Cash from financing

₹32.03

Net change in cash

-₹0.22

Free cash flow

₹62.13

(Values in Cr)
Revenue
Net income

Particulars

Mar 25 (₹ value in crores)

Net income

₹21.52

Cash from operations

₹36.40

Cash from investing

-₹30.70

Cash from financing

-₹3.47

Net change in cash

-₹0.15

Free cash flow

₹68.68

Particulars

Mar 24 (₹ value in crores)

Net income

₹15.89

Cash from operations

₹27.61

Cash from investing

-₹51.53

Cash from financing

₹27.44

Net change in cash

₹0.37

Free cash flow

₹87.17

Particulars

Mar 23 (₹ value in crores)

Net income

₹16.87

Cash from operations

₹37.60

Cash from investing

-₹74.37

Cash from financing

₹41.09

Net change in cash

₹0.06

Free cash flow

₹119.80

Particulars

Mar 22 (₹ value in crores)

Net income

₹19.00

Cash from operations

₹35.59

Cash from investing

-₹90.40

Cash from financing

₹54.56

Net change in cash

-₹0.05

Free cash flow

₹133.12

Particulars

Mar 21 (₹ value in crores)

Net income

₹13.24

Cash from operations

₹15.31

Cash from investing

-₹46.83

Cash from financing

₹32.03

Net change in cash

-₹0.21

Free cash flow

₹62.14

Sakar Healthcare Limited technical summary

₹437.3
+ 0.58 ▲
16
Bearish
0
Bullish
5 Day410.1
10 Day402.5
12 Day401.4
20 Day399.8
26 Day399.3
50 Day395.8
100 Day383.1
200 Day362.3
5 Day403.2
10 Day394.1
12 Day397.5
20 Day395.4
26 Day397.6
50 Day399.7
100 Day383
200 Day355.8

435.58

PIVOT

First support
₹406.17
First resistance
₹464.17
Second support
₹377.58
Second resistance
₹493.58
Third support
₹348.17
Third resistance
₹522.17
RSI
64.8
ADX
13.32
MACD
2.02
Williams % R
-31.51
Commodity Channel Index (CCI)
186.72
Date
05 Feb 2026
Same day
1,97,553
Week
35,236
Month
22,509
1 year
0.74
3 years
0.83
Over 1 month
5.84%
Over 1 year
55.24%
Over 3 months
11.44%
Over 3 years
23.56%
Over 6 months
28.24%
Over 6 years
33.51%

Investment Returns

Over 1 Month5.84%
Over 3 Months11.44%
Over 6 Months28.24%
Over 1 Year55.24%

Sakar Healthcare Limited Shareholding pattern


Public
22.73%
Promoter holdings
52.85%
FII
13.04%
DII
11.35%
Promoter shares
0%
Promoter sharesShareCategory

Sanjay S Shah

1,00,08,543 (44.98%)

Shareholding of Promoter and Promoter Group

Tata Capital Healthcare Fund Ii

23,09,910 (10.38%)

Public Shareholding

Hbm Healthcare Investments (cayman) Ltd

15,00,000 (6.74%)

Public Shareholding

Shah Aarsh

14,07,500 (6.33%)

Shareholding of Promoter and Promoter Group

Cobra India (mauritius) Limited

13,71,796 (6.17%)

Public Shareholding

Promoter sharesShareCategory
Sanjay S Shah1,00,08,543 (44.98%)Shareholding of Promoter and Promoter Group
Tata Capital Healthcare Fund Ii23,09,910 (10.38%)Public Shareholding
Hbm Healthcare Investments (cayman) Ltd15,00,000 (6.74%)Public Shareholding
Shah Aarsh14,07,500 (6.33%)Shareholding of Promoter and Promoter Group
Cobra India (mauritius) Limited13,71,796 (6.17%)Public Shareholding
Hi-tech Chemicals Limited5,45,034 (2.45%)Public Shareholding
Ritaben Shah2,45,000 (1.1%)Shareholding of Promoter and Promoter Group
Shah Ayushi1,00,000 (0.45%)Shareholding of Promoter and Promoter Group

About SAKAR HEALTHCARE LIMITED

Sakar Healthcare Limited was incorporated as a Private Limited Company under the name 'Sakar Healthcare Private Limited on 26th March 2004. Subsequently, the Company was converted into Public Limited Company on March 27, 2015 and the name of the Company was changed to 'Sakar Healthcare Limited. The Company is promoted by Sanjay Shah, Rita Shah and Aarsh Shah. The Company is engaged in manufacturing of Pharmaceutical products providing Liquid Orals, Cephalosporin Tablet, Capsule, Dry Powder Syrup, Dry Powder Injections, Liquid Injectables (SV

Parent Organisation

Indian Private

NSE Symbol

SAKAR

Founded

2004

SAKAR HEALTHCARE LIMITED CORPORATE ACTION

No data available.

View more stocks

What’s trending

All stocks

LOYALTEX

LOYAL TEXTILE MILLS LTD.

304.8
+50.8 (+20%)
GORANIN

GORANI INDUSTRIES LTD.

63.61
+10.6 (+20%)
NIRAJISPAT

NIRAJ ISPAT IND LTD

257.41
+42.9 (+20%)
STRATMONT

STRATMONT INDUSTRIES LIMITED

90.01
+15 (+20%)
View all

Top gainers

ITC

ITC LTD

325.8
+15.60 (+5.03%)
KOTAKBANK

KOTAK MAHINDRA BANK LTD

422.35
+13.60 (+3.33%)
HINDUNILVR

HINDUSTAN UNILEVER LTD.

2424.2
+69.80 (+2.96%)
BHARTIARTL

BHARTI AIRTEL LIMITED

2038.4
+46.00 (+2.31%)
View all

Top losers

HDFCLIFE

HDFC LIFE INS CO LTD

703.5
-17.20 (-2.39%)
TCS

TATA CONSULTANCY SERV LT

2941.6
-49.90 (-1.67%)
TECHM

TECH MAHINDRA LIMITED

1619.9
-26.30 (-1.60%)
BAJAJ-AUTO

BAJAJ AUTO LIMITED

9518.5
-128.50 (-1.33%)
View all

Frequently asked questions


Related videos


Related tags


You are here


Related links

Disclaimer

*Disclaimer for Bajaj Finance Limited (‘BFL’):

Stock trading business is carried by Bajaj Financial Securities Limited ("BFSL"), a broker and Depository Participant registered with Securities Exchange Board of India and offers various products/services related to Securities market (Securities market products/services). BFL merely facilitates display of data shared by BFSL on its webpage/mobile application. Such data received from BFSL, or any of its service providers is on “as is” basis. BFL does not make any representation or warranty, express or implied, regarding accuracy, completeness of such data displayed herein.

When you opt to avail the Securities market products/services of BFSL by clicking on the BFSL weblink/mobile app, you will be redirected to BFSL's web page/mobile app for initiation and completion of the transaction. You are supposed to exercise independent diligence by reading all the related documents carefully before deciding to invest in Securities market Products/services.

BFL is a Non-Banking Financial Company carrying the business of acceptance of deposits and providing lending solutions to Retail and Corporate customers. BFL does not offer nor advice on Securities market products/services and shall not be liable or responsible for any of your investment decision."


**Disclaimer: For Bajaj Financial Securities Limited

Investments in the securities market are subject to market risk, read all related documents carefully before investing.

Broking services offered by Bajaj Financial Securities Limited (Bajaj Broking). Reg Office: Bajaj Auto Limited Complex, Mumbai –Pune Road Akurdi Pune 411035. Corporate Office: Bajaj Financial Securities Limited, 1st Floor, Mantri IT Park, Tower B, Unit No 9 & 10, Viman Nagar, Pune, Maharashtra 411014. SEBI Registration No.: INZ000218931 | BSE Cash/F&O/CDS (Member ID:6706) | NSE Cash/F&O/CDS (Member ID: 90177) | DP registration No: IN-DP-418-2019 | CDSL DP No.: 12088600 | NSDL DP No. IN304300 | AMFI Registration No.: ARN –163403.

Details of Compliance Officer: Mr. Boudhayan Ghosh (For Broking/DP/Research) | Email: compliance_sec@bajajbroking.in | Contact No.: 020-4857 4486. For any investor grievances write to compliance_sec@bajajbroking.in/ compliance_dp@bajajbroking.in (DP related)

This content is for educational purpose only. Securities quoted are exemplary and not recommendatory.

Research Services are offered by Bajaj Broking as Research Analyst under SEBI Regn: INH000010043.

For more disclaimer, check here: https://www.bajajbroking.in/disclaimer


Powered by Bajaj Financial Securities Limited (Bajaj Broking)